PIK3CA and breast carcinoma: Some scholars have compared CLBC with non-claudin-low breast cancer and found that CLBC has few gene mutations, low genetic instability, a low frequency of TP53 and PIK3CA mutations, and minimal MYC and MDM4 gain (52).